Company information:
Icon Clinical Research (U.K.) No. 3 Limited (No: 06522869)
Address: 500 SOUTH OAK WAY GREEN PARK, READING, RG2 6AD, ENGLAND
Status: Active
Incorporated: 03-Apr-2008
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 29-Mar-2025
Industry Class: 70229 - Management consultancy activities other than financial management
Current Director: TRACY BROWN ( DOB: Oct-1978 From: Jun-2023 )
Current Director: SIMON HOLMES ( DOB: Dec-1966 From: Jul-2017 )
Current Secretary: ERINA FOX ( From: Jul-2017 )
Resigned Director: MICHAEL GLEESON ( DOB: Nov-1978 From: Jul-2017 To: Oct-2022 )
Resigned Director: JAMES MICHAEL KARIS ( From: Feb-2014 To: Jul-2017 )
Resigned Director: WILLIAM CHRISTIAN MAIER ( DOB: Oct-1963 From: Mar-2008 To: Jul-2017 )
Resigned Director: NIGEL GRANVILLE PAGE ( DOB: Jan-1961 From: Jan-2011 To: Jul-2017 )
Resigned Secretary: DANIEL RAYMOND KUBITZA ( From: Mar-2009 To: Oct-2012 )
Persons of Significant Control:
Icon Public Limited Company, Icon South County Business Park, Leopardstown, Dublin 18, Ireland: Ownership of shares – 75% or more (Notified: 2017-07-27, Ceased: 2017-11-15)
Icon Clinical Research (U.K.) Limited, 500 South Oak Way, Green Park, Reading, RG2 6AD, United Kingdom: Ownership of shares – 75% or more (Notified: 2017-11-15)
Mr Jean-Louis Marc Menard, 80 Moorbridge Road, Maidenhead, SL6 8BW, England: Has significant influence or control (Notified: 2017-05-19, Ceased: 2017-07-27)
Mr Philippe Alain Dhamelincourt, 80 Moorbridge Road, Maidenhead, SL6 8BW, England: Has significant influence or control (Notified: 2017-05-19, Ceased: 2017-07-27)
Mr Bernard Marcel Jambon, 80 Moorbridge Road, Maidenhead, SL6 8BW, England: Has significant influence or control (Notified: 2017-05-19, Ceased: 2017-07-27)